These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8993240

  • 1. Heparin coating with aprotinin reduces blood activation during coronary artery operations.
    Baufreton C, Jansen PG, Le Besnerais P, te Velthuis H, Thijs CM, Wildevuur CR, Loisance DY.
    Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass.
    Baufreton C, Le Besnerais P, Jansen P, Mazzucotelli JP, Wildevuur CR, Loisance DY.
    Perfusion; 1996 Nov; 11(6):437-43. PubMed ID: 8971943
    [Abstract] [Full Text] [Related]

  • 3. Reduction of blood activation in patients receiving aprotinin during cardiopulmonary bypass for coronary artery surgery.
    Baufreton C, Velthuis HT, Jansen PG, Besnerais PL, Wildevuur CH, Loisance DY.
    ASAIO J; 1996 Nov; 42(5):M417-23. PubMed ID: 8944919
    [Abstract] [Full Text] [Related]

  • 4. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H, Jansen PG, Hack CE, Eijsman L, Wildevuur CR.
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [Abstract] [Full Text] [Related]

  • 5. Elastase release following myocardial ischemia during extracorporeal circulation (ECC) -- marker of ongoing systemic inflammation?
    Boeken U, Feindt P, Schulte HD, Gams E.
    Thorac Cardiovasc Surg; 2002 Jun; 50(3):136-40. PubMed ID: 12077684
    [Abstract] [Full Text] [Related]

  • 6. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E, Thelin S, Svennevig JL, Jansen P, Mollnes TE, Hack E, Venge P, Moen O, Brockmeier V, Dregelid E, Haldén E, Hagman L, Videm V, Pedersen T, Mohr B.
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [Abstract] [Full Text] [Related]

  • 7. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting.
    Jansen PG, Baufreton C, Le Besnerais P, Loisance DY, Wildevuur CR.
    Ann Thorac Surg; 1996 May; 61(5):1363-6. PubMed ID: 8633942
    [Abstract] [Full Text] [Related]

  • 8. [Effect of aprotinin on blood loss reduction after extracorporeal circulation].
    Ueyama K, Kawasuji M, Sakakibara N, Tedoriya T, Takahashi M, Watanabe Y.
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Oct; 41(10):2093-9. PubMed ID: 7693833
    [Abstract] [Full Text] [Related]

  • 9. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [Abstract] [Full Text] [Related]

  • 10. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A, Huebler S, Merkle F, Hentschel T, Gründel M, Krabatsch T, Tambeur L, Praus M, Habazettl H, Kuebler WM, Kuppe H.
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [Abstract] [Full Text] [Related]

  • 11. 'High dose' aprotinin and heparin-coated circuits: clinical efficacy and inflammatory response.
    Parolari A, Alamanni F, Gherli T, Salis S, Spirito R, Foieni F, Rossi F, Bertera A, Oddono P, Biglioli P.
    Cardiovasc Surg; 1999 Jan; 7(1):117-27. PubMed ID: 10073771
    [Abstract] [Full Text] [Related]

  • 12. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M, Demircin M, Guvener M, Peker O, Yilmaz M.
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [Abstract] [Full Text] [Related]

  • 13. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N, Brinkmann T, Minami K, Tenderich G, Schulte-Eistrup S, Kleesiek K, Körfer R.
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [Abstract] [Full Text] [Related]

  • 14. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
    Khalil PN, Ismail M, Kalmar P, von Knobelsdorff G, Marx G.
    Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
    [Abstract] [Full Text] [Related]

  • 15. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 16. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.
    Boonstra PW, Gu YJ, Akkerman C, Haan J, Huyzen R, van Oeveren W.
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):289-92. PubMed ID: 8283898
    [Abstract] [Full Text] [Related]

  • 17. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM, Jackson LR, Chatwin C, Smolich JJ.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations.
    Misfeld M, Dubbert S, Eleftheriadis S, Siemens HJ, Wagner T, Sievers HH.
    Ann Thorac Surg; 1998 Sep; 66(3):792-9. PubMed ID: 9768932
    [Abstract] [Full Text] [Related]

  • 19. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG, Wildevuur CR, Sturk A, Eijsman L.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [Abstract] [Full Text] [Related]

  • 20. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ, de Haan J, Brenken UP, de Boer WJ, Prop J, Van Oeveren W.
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.